Effects of probiotic yoghurt on symptoms and intestinal microbiota in patients with irritable bowel syndrome

International Journal of Dairy Technology

Volumn 66, Issue 2, 2013, Pages 243-255

  Lee, Jin ^a   Rheem, Sungsue ^a   Yun, Bohyun ^b   Ahn, Youngjun ^a   Joung, Jaeyeon ^a   Lee, Suk Jun ^a   Oh, Sejong ^b   Chun, Taehoon ^a   Rheem, Insoo ^c   Yea, Hyun Soo ^d   Lim, Kwang Sei ^d   Cha, Jae Myung ^e   Kim, Saehun ^a  

^a Korea University   (South Korea)

^b Chonnam National University   (South Korea)

^c Dankook University   (South Korea)

^d AmorePacific Corporation   (South Korea)

^e Kyung Hee University Hospital   (South Korea)

Author keywords

DGGE; Faecal microbiota; IBS symptom; Irritable bowel syndrome; Probiotic yoghurt

Indexed keywords

LACTOBACILLUS RHAMNOSUS;

EID: 84875874729     PISSN: 1364727X     EISSN: 14710307     Source Type: Journal    
DOI: 10.1111/1471-0307.12028     Document Type: Article

References (46)

1. Bausserman M and Michail S (2005) The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. Journal of Pediatrics 147 197-201.
2. Bezkorovainy A (2001) Probiotics: determinants of survival and growth in the gut. American Journal of Clinical Nutrition 73 399S-405S.
3. Bibiloni R, Fedorak R N, Tannock G W, Madsen K L, Gionchetti P, Campieri M, De Simone C and Sartor R B (2005) VSL#3 Probiotic-mixture induces remission in patients with active ulcerative colitis. American Journal of Gastroenterology 100 1-8.
4. Biller J A, Katz A J, Flores A F, Buie T M and Gorbach S L (1995) Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. 1. Journal of Pediatric Gastroenterology and Nutrition 21 224-226.
5. Brenner D M, Moeller M J, Chey W D and Schoenfeld P S (2009) The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. American Journal of Gastroenterology 104 1033-1049.
6. Brigidi P, Vitali B, Swennen E, Bazzocchi G and Matteuzzi D (2001) Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Research in Microbiology 152 735-741.
7. Chadwick V S, Chen W, Shu D, Paulus B, Bethwaite P, Tie A and Wilson I (2002) Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122 1778-1783.
8. Claesson M J, Van Sinderen D and O'Toole P W (2008) Lactobacillus phylogenomics-towards a reclassification of the genus. International Journal of Systematic and Evolutionary Microbiology 58 2945-2954.
9. Collins S M (1996) The immuno modulatin of enteric neuromuscular functions. Implication for motility and inflammatory disorders. Gastroenterology 111 1683-1699.
10. Drossman D A, Camilleri M, Mayer E A and Whitehead W E (2002) AGA technical review on irritable bowel syndrome. Gastroenterology 123 2108-2131.
11. Elizabeth C V and Susan L (2010) Use of probiotics in gastrointestinal disorders: what to recommend? Therapeutic Advances in Gastroenterology 3 307-319.
12. Fukushima K, Sasaki I, Ogawa H, Naito H, Funayama Y and Matsuno S (1999) Colonization of microflora in mice: mucosal defense against luminal bacteria. Journal of Gastroenterology 34 54-60.
13. Fuller R (1991) Probiotics in human medicine. Gut 32 439-442.
14. Goldin B R and Gorbach S L (1976) The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. Journal of the National Cancer Institute 57 371-375.
15. Goldin B R and Gorbach S L (1977) Alterations in fecal microflora enzymes related to diet, age, lactobacillus supplements, and dimethylhydrazine. Cancer 40 2421-2426.
16. Goldin B R, Swenson L, Dwyer J, Sexton M and Gorbach S L (1980) Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. Journal of the National Cancer Institute 64 255-261.
17. Gustafsson A, Berstad A, Lund-Tonnesen S, Midtvedt T and Norin E (1999) The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea. Scandinavian Journal of Gastroenterology 34 580-622.
18. He F, Morita H, Ouwehand A C, Hosoda M, Hiramatsu M, Kurisaki J, Isolauri E, Benno Y and Salminen S (2002) Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiology and Immunology 46 781-785.
19. Helwig U, Lammers K M, Rizzello F et al. (2006) Lactobacilli, Bifidobacterium animalis subsp. and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World Journal of Gastroenterology 12 5978-5986.
20. Heyman M and Ménard S (2002) Probiotic microorganisms: how they affect intestinal pathophysiology. Cellular and Molecular Life Sciences 59 1-15.
21. Isolauri E, Kirjavainen P V and Salminen S (2002) Probiotics - a role in the treatment of intestinal infection and inflammation. Gut 50 III54-III59.
22. Kajander K, Hatakka K, Poussa H, Färkkilä M and Korpela R (2005) A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Alimentary Pharmacology & Therapeutics 22 387-394.
23. Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J and Palva A (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133 24-33.
24. Ling W H, Korpela R, Mykkänen H and Salminen S (1994) Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. The Journal of Nutrition 124 18-23.
25. Longstreth G F, Grant-Thompson W, Chey W D, Houghton L A, Mearin F and Spiller R C (2006) Functional bowel disorders. Gastroenterology 130 1480-1491.
26. Mitsuoka T, Morishita Y, Kaneuchi C, Yamamota S and Ogata M (1969) A simple method ('Plate-in-bottle method') for the cultivation of fastidious anaerobes. Japanese Journal of Microbiology 13 383-385.
27. Muyzer G, de-Waal E C and Uitterlinden A E (1993) Profiling of complex microbial populations by denaturinggradient gel electrophoresis analysis of polymerase chainreaction-amplified genes coding for 16S rRNA. Applied and Environmental Microbiology 59 695-700.
28. Myzer G (1998) Structure, function and dynamics of microbial communities: the molecular biological approach.In Advances in Molecular Ecology, NATO Science Series. pp 87-117. Carvalho G R ed. Amsterdam, The Netherlands: IOS Press.
29. Naidu A S, Bidlack W R and Clemens R A (1999) Probiotic spectra of lactic acid bacteria (LAB). Critical Reviews in Food Science and Nutrition 38 13-126.
30. Niedzielin K and Kordecki H (1996) Therapeutic usefulness of 'ProViva' solution in the treatment of irritable bowel syndrome and hemorrhoids. Presented at the Symposium of Gastroenterology, Heiligenstadt, Germany.
31. Oberhelman R A, Gilman R H, Sheen P, Taylor D N, Black R E, Cabrera L, Lescano A G, Meza R and Madico G (1999) A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. Journal of Pediatrics 134 15-20.
32. Oksanen P J, Salminen S, Saxelin M, Hämäläinen P, Ihantola-Vormisto A, Muurasniemi Isoviita L, Nikkari S, Oksanen T, Pörsti I and Salminen E (1990) Prevention of travellers' diarrhoea by Lactobacillus GG. Annals of Medicine 22 53-56.
33. Ouwehand A C, Salminen S and Isolauri E (2002) Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek 82 279-289.
34. Riegler G and Esposito I (2001) Bristol scale stool form. A still valid help in medical practice and clinical research. Techniques in Coloproctology 5 163-164.
35. Sartor R B (2004) Therapeutic manipulation of the enteric microfl ora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126 1620-1633.
36. Schultz M, Veltkamp C, Dieleman L A, Grenther W B, Wyrick P B, Tonkonogy S L and Sartor R B (2002) Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflammatory Bowel Diseases 8 71-80.
37. Shanahan F (2000) Therapeutic manipulation in gut flora. Science 289 1211-1312.
38. Shanahan F (2007) Irritable bowel syndrome: shifting the focus toward the gut microbiota. Gastroenterology 133 340-342.
39. Silk D B (2003) Management of irritable bowel syndrome: start of a new era? European Journal of Gastroenterology & Hepatology 15 679-696.
40. Simon G L and Gorbach S L (1986) The human intestinal microflora. Digestive Diseases and Sciences 31 147S-162S.
41. Spiller R C, Jenkins D, Thornely J P, Hebden P M, Wright T, Skinner M and Neal K R (2000) Increased rectal mucosal enteroendocrine cells, Lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47 804-811.
42. Szajewska H, Kotowska M, Mrukowicz J Z, Armanska M and Mikolajczyk W (2001) Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. Journal of Pediatrics 138 361-365.
43. Talley N J, Phillips S F, Wiltgen C M, Zinsmeister A R and Melton L J III (1990) Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clinic Proceedings 65 1456-1479.
44. Vandenplas Y and Benninga M (2009) Probiotics and functional gastrointestinal disorders in children. Journal of Pediatric Gastroenterology and Nutrition 48 S107-S109.
45. Whorwell P J, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F and Quigley E M (2006) Efficacy of an encapsulated probiotics, Bifidobacterium infantis 35624 in women with irritable bowel syndrome. American Journal of Gastroenterology 101 1581-1590.
46. Yli-Knuuttila H, Snall J, Kari K and Meurman J H (2006) Colonization of Lactobacillus rhamnosus GG in the oral cavity. Oral Microbiology and Immunology 21 129-131.